Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-20-003417)

Filing Details

Accession Number:: 0001179110-20-003417
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-10 17:33:42
Reporting Period:: 2020-03-06

Accepted Time:: 2020-03-10 17:33:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1730430	Kiniksa Pharmaceuticals Ltd.	KNSA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532218	K Sanj Patel	C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM11	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Shares	Disposition	2020-03-06	33,115	$20.00	212,570	No	4	S	Indirect	Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Shares	109,795	Indirect	Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016

Footnotes

The sale of Class A Common Shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 6, 2019.